These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6794603)

  • 1. A heterologous immunoglobulin chain recombinant carries a distinct site for dinitrophenyl and obeys the common hapten binding mechanism.
    Zidovetzki R; Blatt Y; Pecht I
    Biochemistry; 1981 Aug; 20(17):5011-8. PubMed ID: 6794603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common mechanism of hapten binding to immunoglobulins and their heterologous chain recombinants.
    Zidovetzki R; Blatt Y; Glaudemans CP; Manjula BN; Pecht I
    Biochemistry; 1980 Jun; 19(12):2790-5. PubMed ID: 6772205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic evidence for hapten-induced conformational transition in immunoglobin MOPC 460.
    Lancet D; Pecht I
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3549-53. PubMed ID: 1068466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimerization kinetics of the IgE-class antibodies by divalent haptens. I. The Fab-hapten interactions.
    Schweitzer-Stenner R; Licht A; Pecht I
    Biophys J; 1992 Aug; 63(2):551-62. PubMed ID: 1420897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of 2,4-dinitrophenyl derivatives by the light chain dimer obtained from immunoglobulin A produced by MOPC-315 mouse myeloma.
    Schechter I; Ziv E
    Biochemistry; 1976 Jun; 15(13):2785-90. PubMed ID: 820373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional examination of hapten-binding derivatives from a murine myeloma protein with immunoglobulin features.
    Merz DC; Litman GW; Good RA
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1940-4. PubMed ID: 4525470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interchain disulfide bond on hapten binding properties of light chain dimer of protein 315.
    Zidovetski R; Licht A; Pecht I
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5848-52. PubMed ID: 118454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function relations in phosphorylcholine-binding mouse myeloma proteins.
    Goetze AM; Richards JH
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2109-12. PubMed ID: 405672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloma proteins with anti-hapten antibody activity: epsilon-2,4-dinitrophenyl lysine binding by the protein produced by mouse plasmacytoma MOPC-460.
    Jaffe BM; Eisen HN; Simms ES; Potter M
    J Immunol; 1969 Oct; 103(4):872-4. PubMed ID: 5349739
    [No Abstract]   [Full Text] [Related]  

  • 10. Circular dichroism of hapten--antibody complexes: characterization of the combining sites of native and reformed MOPC-315 protein, its isolated subunits, and its Fv fragment.
    Rockey JH; Freed RM
    Scand J Immunol; 1976; 5(6-7):655-66. PubMed ID: 824716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contact regions for dinitrophenyl and menadione haptens in an immunoglobulin binding more than one antigen.
    Rosenstein RW; Musson RA; Armstrong MK; Konigsberg WH; Richards FF
    Proc Natl Acad Sci U S A; 1972 Apr; 69(4):877-81. PubMed ID: 4112641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resonance Raman-spectroscopic studies of the hapten features involved in the binding of 2,4-dinitrophenyl haptens by the mouse myeloma proteins MOPC 315 and MOPC 460.
    Kumar K; Phelps DJ; Carey PR; Young NM
    Biochem J; 1978 Nov; 175(2):727-35. PubMed ID: 743221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bivalent hapten-antibody interactions--III. Formation of an unusual polymer by IGA (MOPC 315) upon binding a bivalent hapten.
    Wilder RL; Green G; Schumaker VN
    Immunochemistry; 1975 Jan; 12(1):54-60. PubMed ID: 237832
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulation of Ig gene expression by Ig binding factors. Suppression of alpha-H chain and lambda-2-L chain mRNA accumulation in MOPC-315 by IgA-binding factor.
    Roman S; Moore JS; Darby C; Müller S; Hoover RG
    J Immunol; 1988 May; 140(10):3622-30. PubMed ID: 3129498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The binding of 2,4,6-trinitrophenyl derivatives to the mouse myeloma immunoglobulin A protein MOPC 315.
    Dower SK; Gettins P; Jackson R; Dwek RA; Givol D
    Biochem J; 1978 Jan; 169(1):179-88. PubMed ID: 629744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of the lanthanide- and hapten-binding sites in the Fv fragment from the myeloma protein MOPC 315.
    Dwek RA; Givol D; Jones R; McLaughlin AC; Wain-Hobson S; White AI; Wright C
    Biochem J; 1976 Apr; 155(1):37-53. PubMed ID: 7239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallization with hapten of the Fab' fragment from a mouse IgA myeloma protein with antidinitrophenyl activity.
    Inbar D; Rotman M; Givol D
    J Biol Chem; 1971 Oct; 246(20):6272-5. PubMed ID: 4942559
    [No Abstract]   [Full Text] [Related]  

  • 18. Conformational transitions of antibodies induced by hapten binding.
    Zav'yalov VP; Abramov VM; Skvortzov VG; Troitsky GV
    Biochim Biophys Acta; 1977 Aug; 493(2):359-66. PubMed ID: 560870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of immunoglobulin phenotype in cell culture-adapted lines of two mouse plasmacytomas.
    Hausman SJ; Bosma MJ
    J Exp Med; 1975 Oct; 142(4):998-1010. PubMed ID: 51902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The covalent assembly of MOPC 104 E immunoglobulin M. Identification of a heavy chain dimer, a complex of two heavy chains and one light chain, and a distinctive form of monomer as intracellular intermediates.
    Percy ME; Feinstein A; Baumal R
    Can J Biochem; 1978 Mar; 56(3):190-6. PubMed ID: 416890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.